Swiss Life Funds (LUX) Equity Europe High Dividend EUR R Dis

Performance (in EUR)

Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.

Performance

1 month 0.16%
Current year 12.84%
3 years p.a. 10.32%
5 years p.a. n.a.
10 years p.a. n.a.
Since inception p.a. n.a.

Rolling performance in %

Key figures

YTD 1 year 3 years 5 years 10 years
Performance 12.84% 10.42% 34.30% n.a. n.a.
Maximum profit on monthly basis 5.76% 5.76% 6.28% n.a. n.a.
Maximum loss on monthly basis -1.16% -4.71% -7.39% n.a. n.a.
Max drawdown -11.87% -11.87% -13.39% n.a. n.a.
Volatility 13.95% 12.85% 11.80% n.a. n.a.
Sharpe ratio 1.71 0.58 0.57 n.a. n.a.
Maximum continuous profit in months 3 3 3 n.a. n.a.
Maximum continuous loss in months 1 1 2 n.a. n.a.
Positive months / profit duration in months 5 9 21 n.a. n.a.
Negative months / loss duration in months 2 4 15 n.a. n.a.

Master data

Fund name Swiss Life Funds (LUX) Equity Europe High Dividend EUR R Dis
Fund management company Swiss Life Asset Managers Luxembourg
Fund domicile Luxembourg
Inception date 05 July 2022
ISIN LU2477750728
Fund currency EUR
Appropriation of income distributing
Issuing commission
Ongoing charges under PRIIP KID as at 01 January 2025 1.74%
End of financial year 31 August
Paying agent
Fund volume as at 30 April 2025 41.77 Mio. EUR
Net asset value (NAV) as at 14 July 2025 134.26 EUR

Portfolio structure

Top holdings of fund volume (in %)

Zurich Insurance Group 6.17%
Novartis AG 5.71%
Roche Hldg. Genußsch. 5.69%
Rio Tinto PLC 4.97%
British American Tobacco 4.61%
Allianz SE 4.08%
AXA S.A. 3.22%
Sanofi 3.22%
Imperial Brands PLC 3.14%
Reckitt Benckiser 2.89%

Asset allocation

Currency

Countries

Sectors